GSK Shares Fall Despite Better-Than-Expected Quarterly Results

GSK shares fell as much as 7% on 28 October, later easing to a 5.5% drop, even though third-quarter results beat analysts' expectations. The Guardian attributed the fall to weaker sales and rising costs. Pre-tax profit fell 19% to £1.9bn, and restructuring charges reached £318m, with more to come.